Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-26T08:14:27.439Z Has data issue: false hasContentIssue false

9 - Treatment of delirium in critical care

Published online by Cambridge University Press:  05 December 2011

Valerie Page
Affiliation:
Watford General Hospital
E. Wesley Ely
Affiliation:
Vanderbilt University School of Medicine
Get access

Summary

Introduction

Considering the seriousness of delirium, it is surprising (and frustrating) that the availability of effective pharmacological treatments is limited. This is explained in part by the fact that the pathophysiology is poorly understood – as outlined in Chapter 4. As a clinical syndrome, delirium can be compared to the acute respiratory distress syndrome (ARDS) that has similarly poor outcomes with no magic bullet to make it all better.

Do the drugs used for delirium rectify the neurotransmitter balance or simply alleviate the symptoms? Should we use drugs to treat delirium at all?

As with many conditions in ICU, the most important aspect of treatment is determining and dealing with the cause(s) of the problem. You cannot beat delirium if you do not address all treatable precipitating factors.

Identify and treat the cause

Delirium is always triggered by some ‘event’. It may be a relatively small insult in the vulnerable patient, for instance a new urinary tract infection or a single dose of zopiclone in an elderly patient with pre-existing cognitive impairment. Keep in mind that the two commonest causes of new onset delirium in ICU are infection and drugs. Importantly, remember that simple measures such as restoring oxygenation and blood pressure may be enough to clear delirium in a sick patient. Delirium is a clinical sign not to be ignored!

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

http://www.learnicu.org/Clinical_Practice/Systems/Neurology/Pages/Depression_and_Sedation.aspx.
Vella-Brincat, J and Macleod, AD.Haloperidol in palliative care. Palliative Medicine 2004; 18: 195–201.CrossRefGoogle ScholarPubMed
Shen, W.A history of antipsychotic drug development. Comprehensive Psychiatry 1999; 40: 407–14.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×